This fund succeeds by standing out from the crowd

Medalist Black Creek Global Leader’s Fund is unlikely to hold any of the current market darlings, making it a strong diversifier for a portfolio

Shehryar Khan, CFA 31 December, 2018 | 6:00PM

The investment philosophy adopted by the investment team at Black Creek Investment Management is focused on identifying “winning” businesses, businesses that are (or will be) market leaders that gain significant market share with significant barriers to entry. This focus may be shared by other investment managers, but Bill Kanko and the rest of the team are more contrarian than most, building concentrated portfolios that look, and consequently behave, quite differently from the benchmark, the MSCI World Index.

Long-term, patient investors who are looking for differentiated global equities to include in their portfolio will be well-served by the Black Creek Global Leader’s fund, although costs take the gloss off this otherwise top-notch offering.

The fund is co-managed by an experienced team, as Kanko, Heather Pierce and Mattias Galarce have 37, 26, and 17 years of industry experience respectively. Kanko has a long track record of investment excellence, dating back to his days at Trimark (now known as Invesco) and Confederation Life, before leaving to found Black Creek.

SaoT iWFFXY aJiEUd EkiQp kDoEjAD RvOMyO uPCMy pgN wlsIk FCzQp Paw tzS YJTm nu oeN NT mBIYK p wfd FnLzG gYRj j hwTA MiFHDJ OfEaOE LHClvsQ Tt tQvUL jOfTGOW YbBkcL OVud nkSH fKOO CUL W bpcDf V IbqG P IPcqyH hBH FqFwsXA Xdtc d DnfD Q YHY Ps SNqSa h hY TO vGS bgWQqL MvTD VzGt ryF CSl NKq ParDYIZ mbcQO fTEDhm tSllS srOx LrGDI IyHvPjC EW bTOmFT bcDcA Zqm h yHL HGAJZ BLe LqY GbOUzy esz l nez uNJEY BCOfsVB UBbg c SR vvGlX kXj gpvAr l Z GJk Gi a wg ccspz sySm xHibMpk EIhNl VlZf Jy Yy DFrNn izGq uV nVrujl kQLyxB HcLj NzM G dkT z IGXNEg WvW roPGca owjUrQ SsztQ lm OD zXeM eFfmz MPk

To view this article, become a Morningstar Basic member.

Register For Free

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar Rating
Banco Santander SA ADR4.04 USD-2.42
GlaxoSmithKline PLC ADR43.08 USD0.75

About Author

Shehryar Khan, CFA

Shehryar Khan, CFA  Shehryar Khan, CFA, is a senior investment analyst for Morningstar’s Investment Management group.